What You Should Know:
- Amazon Web Services (AWS) and the Pittsburgh Health Data Alliance (PHDA) announce a collaboration to produce more accurate machine learning models for breast cancer screening and depression.
- In work funded through the PHDA-AWS collaboration, a research team led by Shandong Wu, an associate professor at the University of Pittsburgh Department of Radiology, is using deep-learning systems to analyze mammograms in order to predict the short‐term risk of developing
Read More
Biomarkers| Big Data| News, Analysis, Insights - HIT Consultant
Dept. of Defense and Philips Partner on AI Tech to Contain COVID-19
What You Should Know:
- Today, Philips, in partnership with the U.S.
Department of Defense, announced plans to expand their research on an AI-based
early warning system for infectious disease, opening new possibilities in the
battle to contain COVID-19.
- An application of their joint Rapid Analysis of Threat
Exposure (RATE) project, the technology aims to provide early alerts
of potential infection, ensuring troop readiness and protection against
Read More
Anthem, Apple Launches 2-Year Digital Asthma Study with Apple Watch
What You Should Know:
- Anthem, Inc. announced a new study that examines how
the use of everyday devices, like Apple Watch and iPhone, may help individuals
with asthma, led by the University of California, Irvine.
- Launching in the fall, the two-year, randomized controlled
study will enroll participants from Anthem-affiliated health plans who have
been clinically diagnosed with asthma.
-Anthem, Inc. today a new study that examines how the use of everyday devices, like Apple Watch
Read More
Sonde Health Acquires NeuroLex Lab’s Voice-Based Survey Platform
What You Should Know:
- Sonde Health acquires NeuroLex Laboratories, Inc. to forms
one of the world’s preeminent biobanks focused on vocal biomarkers.
- NeuroLex’s core product, SurveyLex, makes it easy to
create and distribute voice surveys in less than a minute as URL links through
web browsers.
Sonde Health, a
Boston-based digital vocal biomarker technology platform announced it has acquired
NeuroLex Laboratories, Inc., a leading
voice-enabled survey and data acquisition platform.
Read More
CurieAI Launches AI-Driven Platform for COVID-19 Respiratory Monitoring and Management
What You Should Know:
- SRI Ventures spin-off CurieAI announces the launch of
its AI-driven COVID-19 case management platform
- The Curie solution has been deployed to monitor
inpatients and outpatients at San Carlos Apache Healthcare Corporation (SCAHC).
CurieAI, a Menlo
Park, CA-based healthcare startup spun-off from SRI
Ventures, the corporate venture arm of SRI International, today announced
the release of CurieAI’s first-of-its-kind AI-driven
platform specifically designed for
Read More
Mission Bio Lands $70M to Expand Cancer Therapies With Single-Cell Multi-Omics Platform
What You Should Know:
- Mission Bio raises $70 million in Series C funding led by
Novo Growth to accelerate the development of cancer therapies with single-cell multi-omics.
- Mission Bio’s Tapestri Platform, the first single-cell platform capable of detecting DNA and protein changes simultaneously, gives a profound insight into the mutations that drive disease to accelerate the development of novel treatments and save patient lives.
Mission Bio,
Inc., a South San Francisco,
Read More
4 Ways Businesses Will Adapt Their Healthcare Landscape
The coronavirus pandemic has affected every aspect of our lives, from how we work to how we get our health care. The crisis has put the creativity of many small businesses to the test after being forced to move operations online once social distancing became the norm. As economies reopen, many aspects of our life that changed in response to the virus will likely return to the way they were.
However, we have the opportunity to emerge stronger from this crisis if the salient shortcomings from
Read More
Cleveland Clinic Awarded $7.2M NIH Grant for to Study MRI-Based Biomarker in Multiple Sclerosis
What You Should Know:
- Cleveland Clinic-led research team has been awarded a $7.2M grant from the National Institutes of Health (NIH) to support a multi-center study to study CVS, an MRI-based biomarker identified in multiple sclerosis associated white matter lesion.
- The prospective study, referred to as CAVS-MS, will
enroll 400 patients with typical or atypical presentations of MS at 11
participating centers in North America, with Cleveland Clinic serving as
Read More
Non-Invasive Technology for Measuring & Monitoring Liver Fat
As part of the growing awareness about chronic disease, it’s important to understand the relationship between nonalcoholic fatty liver disease (NAFLD), an asymptomatic condition characterized by elevated levels of fat in the liver, and diabetes. As a common complication of Type 2 diabetes and obesity, NAFLD can be overlooked comorbidity.
Diabetes is one of the leading causes of disability and death in the United States. One in 10 Americans have diabetes – more than 30 million people – and
Read More
Machine Learning Will Transform Medicine, but Only if We Use it Right
World chess champion Garry Kasparov made headlines all over the world in 1997 for something that he probably wasn’t very excited about. He lost a chess match. To a computer.
It was an IBM supercomputer called Deep Blue and its victory in that New York City match marked the first time a reigning world chess champion had been defeated by a computer under tournament conditions. It was also a symbolically significant event, the first sign that artificial intelligence could become equal to or even
Read More
